Literature DB >> 16130819

Genetic and epigenetic control of skeletal muscle development.

Beate Brand-Saberi1.   

Abstract

In recent years our understanding of the molecular processes underlying skeletal myogenesis has improved considerably. Overt myogenesis is preceded by a number of steps leading to the specification of muscle precursor cells. During this period, myogenic precursors express mRNAs for Muscle Regulatory Factors (MRFs) of the bHLH-family of transcription factors: MyoD, Myf5, Myogenin and MRF4. These factors are specific for developing skeletal muscle and their identification belongs to the great achievements in muscle research. Other transcriptional regulators involved in myogenesis are Pax3 and Pax7, as well as the myocyte enhancer factors (MEFs), especially MEF2. Other inhibitory transcription factors may interact with histones to render muscle-specific genes inacessible. More recently, signaling events involving the Wnt-glycoproteins and Sonic Hedgehog have been identified that lead to the induction or expansion of muscle-specific genes during embryogenesis. Sources of these signals were identified to be the neural tube, ectoderm and notochord. Interestingly, a bias towards muscle differentiation already resides in cells of the epiblast. Thus, it can be reasoned that muscle differentiation does not have to be induced, but maybe just derepressed. Apart from inductive or permissive signals involved in differentiation control, other signalling events have been described leading to the definite arrangement of muscle groups in the body. These processes involve the changes in the cytoskeleton, delay of differentiation, cell migration and target recognition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130819     DOI: 10.1016/j.aanat.2004.12.018

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  35 in total

1.  MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras.

Authors:  Jun Liu; Xiao-Ju Luo; An-Wen Xiong; Zeng-di Zhang; Shen Yue; Ming-Sheng Zhu; Steven Y Cheng
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

2.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) regulates myogenesis and beta1 integrin expression in vitro.

Authors:  Gentian Lluri; Garret D Langlois; Paul D Soloway; Diane M Jaworski
Journal:  Exp Cell Res       Date:  2007-06-27       Impact factor: 3.905

3.  Control of developmental regulators by Polycomb in human embryonic stem cells.

Authors:  Tong Ihn Lee; Richard G Jenner; Laurie A Boyer; Matthew G Guenther; Stuart S Levine; Roshan M Kumar; Brett Chevalier; Sarah E Johnstone; Megan F Cole; Kyo-ichi Isono; Haruhiko Koseki; Takuya Fuchikami; Kuniya Abe; Heather L Murray; Jacob P Zucker; Bingbing Yuan; George W Bell; Elizabeth Herbolsheimer; Nancy M Hannett; Kaiming Sun; Duncan T Odom; Arie P Otte; Thomas L Volkert; David P Bartel; Douglas A Melton; David K Gifford; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2006-04-21       Impact factor: 41.582

4.  Essential role for Dicer during skeletal muscle development.

Authors:  Jason R O'Rourke; Sara A Georges; Howard R Seay; Stephen J Tapscott; Michael T McManus; David J Goldhamer; Maurice S Swanson; Brian D Harfe
Journal:  Dev Biol       Date:  2007-08-25       Impact factor: 3.582

5.  Lineage-specific responses to reduced embryonic Pax3 expression levels.

Authors:  Hong-Ming Zhou; Jian Wang; Rhonda Rogers; Simon J Conway
Journal:  Dev Biol       Date:  2007-12-27       Impact factor: 3.582

6.  Do two mutually exclusive gene modules define the phenotypic diversity of mammalian smooth muscle?

Authors:  Erik Larsson; Sean E McLean; Robert P Mecham; Per Lindahl; Sven Nelander
Journal:  Mol Genet Genomics       Date:  2008-05-29       Impact factor: 3.291

Review 7.  Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis.

Authors:  Xiaoping Chen; Yong Li
Journal:  Cell Adh Migr       Date:  2009-10-24       Impact factor: 3.405

8.  A defined long-term in vitro tissue engineered model of neuromuscular junctions.

Authors:  Mainak Das; John W Rumsey; Neelima Bhargava; Maria Stancescu; James J Hickman
Journal:  Biomaterials       Date:  2010-03-25       Impact factor: 12.479

9.  Wnt signalling at the crossroads of nutritional regulation.

Authors:  Jaswinder K Sethi; Antonio J Vidal-Puig
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

10.  SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.

Authors:  Dali Li; Zhiyv Niu; Weishi Yu; Yu Qian; Qian Wang; Qiang Li; Zhengfang Yi; Jian Luo; Xiushan Wu; Yuequn Wang; Robert J Schwartz; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.